Pathfinder

Surrogate Endpoints vs. Clinical Endpoints: Which Evidence Strategy Is Better for Drug Development?

Nice Insight

Pathfinder

Basket vs. Umbrella Clinical Trials: Which Precision Oncology Trial Design Is Better?

Nice Insight

Pathfinder

Adaptive Trials vs. Traditional Randomized Controlled Trials: Which Clinical Trial Design Is Better?

Nice Insight

Basket Trials

Basket Trials and the Future of Rare Cancer Research

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Site-Based vs. Decentralized vs. Hybrid Clinical Trials: Which Model Is Best for Modern Clinical Research?

Nice Insight

Adaptive Trials

Designing for Change: Adaptive Clinical Trials and the Evolving Path to Regulatory Acceptance

Pharma's Almanac

Expedited Pathways

Accelerated Pathways: Are They Delivering on Their Promise?

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

Global Trials

Clinical Trials Without Borders: The Evolution of Global Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Trials

How Artificial Intelligence May Drive the Future of Clinical Trials

James Grote

Nice Insight